Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001437749-20-019141)

Filing Details

Accession Number:: 0001437749-20-019141
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2020-09-01 17:41:25
Reporting Period:: 2020-05-22

Accepted Time:: 2020-09-01 17:41:25
Original Submission Date:: 2020-05-27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1029125	Sun Biopharma Inc.	SNBP	Pharmaceutical Preparations (2834)	870543922

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1652996	T. Michael Cullen	712 Vista Blvd #305 Waconia MN 55387	Exec. Chairman, Pres. & Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-05-22	10,000	$0.00	204,576	No	4	P	Indirect	By Cullen Living Trust Dated April 23, 2009

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Cullen Living Trust Dated April 23, 2009

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	197,995	Direct

Footnotes

Reported securities purchased as one share of common stock and one warrant to purchase one share of common stock for a combined price of $4.00 per "unit."
This report is amended solely to attribute the purchases of the shares and warrants to the reporting person's indirect holdings. The original report incorrectly attributed them to the reporting person's direct holdings.